CLI-05993AA9-01: Therapeutic equivalence of CHF5993 pMDI 100/6/12.5 g HFA-152a in subjects with mild to moderate asthma (TRECONY) (clinicaltrialsregister.eu) - Mar 12, 2026 - P1/2 | N=42 | Not yet recruiting | Sponsor: Chiesi Farmaceutici S.p.A.
New P1/2 trial • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases
|